How to define responders in osteoarthritis
Background Osteoarthritis is a clinical syndrome of failure of the joint accompanied by varying degrees of joint pain, functional limitation, and reduced quality of life due to deterioration of articular cartilage and involvement of other joint structures. Scope Regulatory agencies require relevant...
Main Authors: | Cooper, C. (Author), Adachi, J.D (Author), Bardin, T. (Author), Berenbaum, F. (Author), Flamion, B. (Author), Jonsson, H (Author), Kanis, J.A (Author), Pelousse, F. (Author), Lems, W.F (Author), Pelletier, J.P (Author), Martel-Pelletier, J. (Author), Reiter, S. (Author), Reginster, J.Y (Author), Rizzoli, R. (Author), Bruyere, O. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2013-06.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis
by: Bruyere, O., et al.
Published: (2015) -
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
by: Bruyere, O., et al.
Published: (2014) -
Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
by: Rizzoli, R., et al.
Published: (2013) -
Osteoarthritis: The Challenge of Establishing a Personalised Treatment
by: Johanne Martel-Pelletier, et al.
Published: (2014-06-01) -
Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients
by: Guangju Zhai, et al.
Published: (2019-11-01)